Advertisement
Advertisement
PTGX
Protagonist Therapeutics, Inc
135.97
USDSponsored
-7.40
-5.16%
Nov 05, 12:34 UTC -5
Open
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc Financial Snapshot
| Market Cap | 8.80B |
| Beta | 1.21 |
| Earnings Per Share (EPS) | 1.03 |
| Price-to-Book (P/B) Ratio | 10.72 |
| Operating Margin | 29.40% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | 136.15 |
| Return on Equity (ROE) | 12.03% |
| Current Ratio | 21.71% |
| Free Cash Flow | 169.73M |
